Brokerages Anticipate Integer Holdings Co. (ITGR) Will Announce Quarterly Sales of $361.04 Million
Brokerages expect Integer Holdings Co. (NYSE:ITGR) to post $361.04 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Integer’s earnings, with the highest sales estimate coming in at $361.63 million and the lowest estimate coming in at $360.00 million. Integer posted sales of $359.59 million during the same quarter last year, which suggests a positive year-over-year growth rate of 0.4%. The company is scheduled to announce its next earnings report on Monday, February 26th.
According to Zacks, analysts expect that Integer will report full year sales of $361.04 million for the current financial year. For the next financial year, analysts expect that the business will report sales of $1.47 billion per share, with estimates ranging from $1.47 billion to $1.48 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow Integer.
Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.04. Integer had a net margin of 1.42% and a return on equity of 11.22%. The firm had revenue of $363.31 million during the quarter, compared to analysts’ expectations of $354.83 million. During the same quarter in the prior year, the company earned $0.83 EPS. The company’s revenue was up 4.8% compared to the same quarter last year.
Shares of Integer (ITGR) opened at $44.85 on Friday. Integer has a 52-week low of $29.00 and a 52-week high of $55.20. The firm has a market cap of $1,433.06, a P/E ratio of 71.19, a PEG ratio of 0.95 and a beta of 1.08. The company has a debt-to-equity ratio of 1.95, a current ratio of 2.58 and a quick ratio of 1.37.
In other news, Director William B. Summers, Jr. sold 13,996 shares of the stock in a transaction on Monday, November 27th. The shares were sold at an average price of $49.07, for a total value of $686,783.72. Following the sale, the director now owns 46,179 shares in the company, valued at $2,266,003.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Jeremy Friedman sold 11,229 shares of the stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $46.01, for a total transaction of $516,646.29. Following the completion of the sale, the chief operating officer now owns 15,681 shares in the company, valued at approximately $721,482.81. The disclosure for this sale can be found here. In the last ninety days, insiders sold 86,561 shares of company stock valued at $4,062,886. Corporate insiders own 4.80% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. California Public Employees Retirement System increased its stake in shares of Integer by 4.9% in the second quarter. California Public Employees Retirement System now owns 92,700 shares of the medical equipment provider’s stock worth $4,009,000 after acquiring an additional 4,300 shares during the period. Piedmont Investment Advisors LLC acquired a new stake in shares of Integer in the second quarter worth $260,000. Vanguard Group Inc. increased its stake in shares of Integer by 2.6% in the second quarter. Vanguard Group Inc. now owns 2,790,328 shares of the medical equipment provider’s stock worth $120,682,000 after acquiring an additional 71,154 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in Integer during the second quarter valued at $284,000. Finally, Macquarie Group Ltd. acquired a new stake in Integer during the second quarter valued at $748,000. Hedge funds and other institutional investors own 95.02% of the company’s stock.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.